| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
| Caywood, Emi H |
Alfred I. Du Pont Hosp For Children
United States |
Nemours NCI Community Oncology Research Program (NCORP) |
5UG1CA189958-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Chauhan, Subhash C. |
University Of Texas Rio Grande Valley
United States |
MUC13 Mucin in Colerectal Cancer Health Disparity |
5R01CA204552-05 |
|
Matthew Young, Ph.D. |
| Carlson, Jay W |
Ozark Health Ventures, Llc
United States |
Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) |
5UG1CA189822-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Valdez, Erin G |
Stanford University
United States |
Circadian regulation of cancer therapy-associated neuroinflammation |
5R21CA267135-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
| Irvin, William J |
Southeast Clinical Oncol Res Consortium
United States |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) |
5UG1CA189858-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Mckeon, Frank D. |
University Of Houston
United States |
Clonal Reconstruction and Targeting of the Correa Sequence |
5R01CA241600-05 |
|
Matthew Young, Ph.D. |
| Moore, Timothy David |
Columbus Community Clinical Oncology Prg
United States |
Columbus NCORP RFA-CA-18-016 |
5UG1CA189954-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Salvemini, Daniela |
Saint Louis University
United States |
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity |
5R01CA230512-05 |
|
Rachel Altshuler, Ph.D. |
| Shuck, Sarah C. |
Beckman Research Institute/City Of Hope
United States |
Identification of metabolic adducts associated with prostate cancer progression in African American men Supplement |
3R21CA282612-01S1 |
|
Guillermo Marquez, Ph.D. |